North America Digital Pathology Market Size & Outlook
North America digital pathology market, 2018-2030 (US$M)
Related Markets
North America digital pathology market highlights
- The North America digital pathology market generated a revenue of USD 415.6 million in 2023.
- The market is expected to grow at a CAGR of 7.2% from 2024 to 2030.
- In terms of segment, device was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 415.6 million |
| Market revenue in 2030 | USD 678.2 million |
| Growth rate | 7.2% (CAGR from 2023 to 2030) |
| Largest segment | Device |
| Fastest growing segment | Software |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Device, Storage Systems |
| Key market players worldwide | Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A |
Other key industry trends
- In terms of revenue, North America region accounted for 40.3% of the global digital pathology market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 395.3 million by 2030.
Device was the largest segment with a revenue share of 51.64% in 2023. Horizon Databook has segmented the North America digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2018 to 2030.
The North American market is expected to grow at a steady rate over the coming 7 years, which can be attributed to factors such as increased use of digital pathology and favorable reimbursement scenario in the U.S. to improve quality & efficiency of cancer diagnosis.
Digital pathology has been classified under Class II devices by the U.S. FDA for primary diagnosis. A growing number of initiatives to promote digital pathology use as a tool for enhanced disease diagnosis and advanced pathology practice is creating potential opportunities for the market across the country.
These organizations are striving to promote digital pathology through promoting awareness pertaining to practicalities and strategies adopted for proper implementation and improvement of pathology workflows.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Pathology Market Scope
Digital Pathology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America digital pathology market size, by country, 2018-2030 (US$M)
North America Digital Pathology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
